Eurofarma Laboratórios S.A. Share Price

Stocks

EUFA3

BREUFAACNOR4

Delayed Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
21/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
14/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	22/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	22/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	22/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	22/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	31/12/2018

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
10/01/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
04/12/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
04/12/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 1.96B 1.76B 1.62B 1.47B 2.78B 184B 2.86B 19.37B 7.72B 98.32B 7.35B 7.19B 311B	12.48B 2.23B 2B 1.84B 1.67B 3.16B 209B 3.25B 22.03B 8.78B 112B 8.35B 8.18B 353B
Net income	117M 20.92M 18.76M 17.29M 15.7M 29.72M 1.96B 30.55M 207M 82.48M 1.05B 78.51M 76.85M 3.32B	571M 102M 91.41M 84.25M 76.51M 145M 9.56B 149M 1.01B 402M 5.12B 383M 374M 16.19B
Net Debt	-	-

Projected Income Statement - Annual - Eurofarma Laboratórios S.A.

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company